COVID-19: Morocco’s Sothema to produce China Sinopharm vaccine
Moroccan pharmaceutical firm Sothema will soon start production of 5 million doses a month of China’s Sinopharm COVID-19 vaccine in the North African country.
The Moroccan government made the announcement at a ceremony chaired by King Mohammed VI during which Sinopharm and Sothema, whose formal name is Société Thérapeutique Marocaine, also signed deals to produce the vaccine in Morocco, which has a population of about 36 million.
The Moroccan government also signed a deal with Sweden’s Recipharm to set up a plant in Morocco to produce other key vaccines.
Morocco, which rolled out a COVID-19 vaccination campaign in January, has inoculated more people against the virus than other African countries.
It had administered 19.23 million doses of the Sinopharm and AstraZeneca vaccines as of July 5.
The country has received 20.4 million doses so far and plan to inoculate everyone over the age of 17.
Morocco has registered 534,550 COVID-19 infections and 9,319 deaths due to the virus.
READ ALSO: Morocco vaccinates over 7mln people against COVID-19
Kamila/Reuters
